Altered Biomarkers in Trophoblast Cells Obtained Noninvasively Prior to Clinical Manifestation of Perinatal Disease

• Published in: Scientific reports Vol. 6; no. 1; p. 32382
• Main Authors: Bolnick, Jay M., Kohan-Ghadr, Hamid-Reza, Fritz, Rani, Bolnick, Alan D., Kilburn, Brian A., Diamond, Michael P., Armant, D. Randall, Drewlo, Sascha
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 23-09-2016; Nature Publishing Group
• Subjects: 631/136; 692/699/2732; Arteries; Cervix; Health risk assessment; Humanities and Social Sciences; Immunofluorescence; multidisciplinary; Perfusion; Placenta; Pre-eclampsia; Preeclampsia; Pregnancy; Science; Science (multidisciplinary); Uterus
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/srep32382

A contributing factor to poor placental perfusion, leading to intrauterine growth restriction and preeclampsia, is the failure of invading extravillous trophoblast (EVT) cells to remodel the maternal uterine arteries during the first and second trimesters of pregnancy. Noninvasive assessment of EVT cells in ongoing pregnancies is possible beginning three weeks after conception, using trophoblast retrieval and isolation from the cervix (TRIC). Seven proteins were semi-quantified by immunofluorescence microscopy in EVT cells obtained between gestational weeks 6 and 20 from pregnancies with normal outcomes (N = 29) and those with intrauterine growth restriction or preeclampsia (N = 12). Significant differences were measured in expression of PAPPA, FLT1, ENG, AFP, PGF, and LGALS14, but not LGALS13 or the lineage marker KRT7. These findings provide for the first time direct evidence of pathology-associated protein dysregulation in EVT cells during early placentation. The TRIC platform provides a novel approach to acquire molecular signatures of EVT cells that can be correlated with pregnancy outcome.